http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20212333-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c53f42ed6dcf6593517e1e1d57e7fa46
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
filingDate 2019-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1758ff27c242b1bed491becce7b0b5d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cc5a9305232438535c731bd9328a05e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbf135a05182e1cbea9714f9014de6f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bd906d66d64d67da40216fd2fbae5f8
publicationDate 2021-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20212333-A1
titleOfInvention COMPOUNDS OF ASCORBIC ACID AND QUINONE IN COMBINATION WITH AN ANTIPARASITIC AGENT FOR THE TREATMENT OF A PARASITIC DISEASE
abstract Referring to compounds of (i) ascorbic acid, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt, solvate or hydrate thereof; (ii) a quinone compound, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof; and (iii) an antiparasitic agent. It also refers to a method for inhibiting parasitic growth, and its use to treat, prevent or alleviate one or more symptoms of Chagas disease, trypanosomiasis, among others.
priorityDate 2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4650

Total number of triples: 28.